Local anaesthetic toxicity
patient risk factors
- extremes of age
- acidosis
- pregnancy (!)
- hyperkalaemia
drug/clinician risk factors
- bupivacaine is reported more cardiotoxic
- blocks in head/neck, or in well vascularised sites with rapid absorption
- large volume blocks
clinical features
CNS effect → resp → cardiovascular
- Perioral numbness/tingling; visual disturbance
- confusion, slurred speech
- lower dose =
- sympathomimetic
- seizures
- higher dose =
- vasoplegic hypotension, bradycardia, QRS prolongation
- coma
pathogenesis
- bupivacaine is especially cardiotoxic
- inhibits L-type calcium channels (?and VGCCs) → disrupt Cardiac contractility
- inhibits acylcarnitine exchange in cardiac mitochondria
management
- Intralipid
- Mechanism is unclear - suggested mechanisms:
- ↓ availability of circulating LA (lipid sink model)
- bupivacaine inhibits fatty acid oxidation → provide extra fatty acids
- intralipid inhibits mitochondrial permeability transition pore
- Dosing:
- 1.5ml/kg of 20% lipid over 1 min AND
- 20% infusion at 15ml/kg/h
related topics
sources/links
https://www.mdpi.com/1422-0067/27/15/6900
https://www.bjaed.org/article/S2058-5349(17)30154-3/fulltext
DOI: 10.1177/0300060520942619 Gao et al 2020